Safety and Efficacy of Adalimumab (Humira) for Hidradenitis Suppurativa (HS) Peri-Surgically
Public ClinicalTrials.gov record NCT02808975. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 4, Double-blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of Adalimumab Used in Conjunction With Surgery in Subjects With Moderate to Severe Hidradenitis Suppurativa
Study identification
- NCT ID
- NCT02808975
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 206 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- Adalimumab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 17, 2016
- Primary completion
- May 15, 2019
- Completion
- Oct 15, 2019
- Last update posted
- May 13, 2020
2016 – 2019
United States locations
- U.S. sites
- 9
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Wallace Medical Group, Inc. /ID# 171289 | Beverly Hills | California | 90211 | — |
| Encino Research Center / T. Jo /ID# 171347 | Encino | California | 91436 | — |
| University of California Irvine /ID# 170054 | Irvine | California | 92697-1385 | — |
| Tulane Univ /ID# 168441 | New Orleans | Louisiana | 70112 | — |
| Beth Israel Deaconess Medical Center /ID# 168438 | Boston | Massachusetts | 02215-5400 | — |
| University of Michigan Hospitals /ID# 200667 | Ann Arbor | Michigan | 48109 | — |
| Univ NC Chapel Hill /ID# 168446 | Chapel Hill | North Carolina | 27514-4220 | — |
| Penn State Hershey Medical Ctr /ID# 168447 | Hershey | Pennsylvania | 17033 | — |
| Rhode Island Hospital /ID# 168439 | Providence | Rhode Island | 02903 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 46 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02808975, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 13, 2020 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02808975 live on ClinicalTrials.gov.